Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005680,
umls-concept:C0030705,
umls-concept:C0043157,
umls-concept:C0051132,
umls-concept:C0076264,
umls-concept:C0205307,
umls-concept:C0220938,
umls-concept:C0221102,
umls-concept:C0681850,
umls-concept:C0857121,
umls-concept:C1524119,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
2
|
pubmed:dateCreated |
1981-4-24
|
pubmed:abstractText |
Urinary aldosterone excretion is commonly determined by assay of aldosterone liberated from the acid-labile metabolite, aldosterone-18-glucuronide (Aldo-18-G), which reflects 5-15% of aldosterone secretion. However, since 3alpha, 5beta-tetrahydroaldosterone (TH-Aldo), the major metabolite, reflects 15-40% of aldosterone excretion, determination of its excretion should usually provide a more accurate index of aldosterone secretion. We have validated a RIA for urinary TH-Aldo and compared its excretion in black and white normal subjects and patients with essential hypertension and primary aldosteronism during consumption of low, normal, and high sodium diets. Urinary TH-Aldo excretion averaged 4.5 +/- 2.0 (mean +/- SD) times that of Aldo-18-G. The ratio of excretion of the two remained relatively constant during low, normal, and high sodium diets. There was no difference in the excretion of TH-Aldo or Aldo-18-G in black vs. white normal subjects or hypertensive patients and no age-related changes in the excretion of either metabolite from 20-60 yr of age. Two of nine patients with primary aldosteronism had normal Also-18-G excretion but elevated TH-Aldo excretion. We conclude that determination of both metabolites increases the diagnostic accuracy for primary aldosteronism.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0021-972X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
52
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
214-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:7462387-Adult,
pubmed-meshheading:7462387-African Continental Ancestry Group,
pubmed-meshheading:7462387-Aldosterone,
pubmed-meshheading:7462387-Diet,
pubmed-meshheading:7462387-European Continental Ancestry Group,
pubmed-meshheading:7462387-Female,
pubmed-meshheading:7462387-Glucuronates,
pubmed-meshheading:7462387-Humans,
pubmed-meshheading:7462387-Hyperaldosteronism,
pubmed-meshheading:7462387-Hypertension,
pubmed-meshheading:7462387-Kinetics,
pubmed-meshheading:7462387-Male,
pubmed-meshheading:7462387-Middle Aged,
pubmed-meshheading:7462387-Radioimmunoassay,
pubmed-meshheading:7462387-Sodium
|
pubmed:year |
1981
|
pubmed:articleTitle |
Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|